Monopar Therapeutics MNPR
NASDAQ MNPR
$80.00 -3.72 (-4.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Share-based Compensation (2017 - 2025)

Updated

Monopar Therapeutics' Share-based Compensation was $1.1 million in Q4 2025, down 70.1% from $3.69 million a year earlier but up 0.4% from the prior quarter.

Analysis

Monopar Therapeutics (MNPR) Share-based Compensation (2017 - 2025) Analysis & Trends

For FY2025, Share-based Compensation at Monopar Therapeutics came in at $4.84 million, up 6.3% from FY2024.

  • Share-based Compensation has now increased for eight consecutive years, with a five-year compound annual growth rate of 29.6% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $4.55 million in FY2024 (+139.9%), $1.9 million in FY2023 (+15.6%), $1.64 million in FY2022 (+11.8%) and $1.47 million in FY2021 (+11.1%).
  • Quarterly Share-based Compensation has moved between $199,122 (Q3 2024) and $3.69 million (Q4 2024) over five years.
  • Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 192.1%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q4 2024 (growth of 678.2%); the worst was Q4 2025 (a decline of 70.1%).
  • Per Business Quant data, MNPR's Share-based Compensation in the three quarters before Q4 2025 was $1.1 million (Q3 2025), $1.28 million (Q2 2025) and $1.36 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Monopar Therapeutics 715.17 Mn 433.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.10 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.36 Mn
Dec 31, 2024 3.69 Mn
Sep 30, 2024 199,122.00
Jun 30, 2024 334,390.00
Mar 31, 2024 328,661.00
Dec 31, 2023 474,206.00
Sep 30, 2023 474,138.00
Jun 30, 2023 473,296.00
Mar 31, 2023 476,209.00
Dec 31, 2022 393,417.00
Sep 30, 2022 390,741.00
Jun 30, 2022 357,293.00
Mar 31, 2022 499,812.00
Dec 31, 2021 350,164.00
Sep 30, 2021 392,065.00
Jun 30, 2021 357,593.00
Mar 31, 2021 368,232.00
API Access

Monopar Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MNPR&period=max&api_key=YOUR_API_KEY